{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T17:39:36Z","timestamp":1789666776670,"version":"4.0.1"},"reference-count":28,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,25]],"date-time":"2023-10-25T00:00:00Z","timestamp":1698192000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["208378\/Z\/17\/Z"],"award-info":[{"award-number":["208378\/Z\/17\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Regional Health - Southeast Asia"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/j.lansea.2023.100317","type":"journal-article","created":{"date-parts":[[2023,12,5]],"date-time":"2023-12-05T23:57:30Z","timestamp":1701820650000},"page":"100317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"special_numbering":"C","title":["Estimating the proportion of relapse following treatment of Visceral Leishmaniasis: meta-analysis using Infectious Diseases Data Observatory (IDDO) systematic review"],"prefix":"10.1016","volume":"22","author":[{"ORCID":"https:\/\/orcid.org\/0009-0004-1404-7333","authenticated-orcid":false,"given":"Rutuja","family":"Chhajed","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2158-846X","authenticated-orcid":false,"given":"Prabin","family":"Dahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sauman","family":"Singh-Phulgenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7653-7371","authenticated-orcid":false,"given":"Matthew","family":"Brack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Naylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyam","family":"Sundar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabiana","family":"Alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Stepniewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe J.","family":"Guerin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.lansea.2023.100317_bib1","series-title":"Leishmaniasis","author":"World Health Organization","year":"2022"},{"issue":"3","key":"10.1016\/j.lansea.2023.100317_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0009302","article-title":"Serious adverse events following treatment of visceral leishmaniasis: a systematic review and meta-analysis","volume":"15","author":"Singh-Phulgenda","year":"2021","journal-title":"PLoS Negl Trop Dis"},{"issue":"4","key":"10.1016\/j.lansea.2023.100317_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/CMR.00048-18","article-title":"Recent development of visceral leishmaniasis treatments: successes, pitfalls, and perspectives","volume":"31","author":"Alves","year":"2018","journal-title":"Clin Microbiol Rev"},{"issue":"9","key":"10.1016\/j.lansea.2023.100317_bib4","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1093\/cid\/cit508","article-title":"One-Year follow-up of immunocompetent male patients treated with miltefosine for primary visceral leishmaniasis in Bihar, India","volume":"57","author":"Burza","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"11","key":"10.1016\/j.lansea.2023.100317_bib5","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1093\/cid\/cit102","article-title":"Increasing failure of miltefosine in the treatment of kala-azar in Nepal and the potential role of parasite drug resistance, reinfection, or noncompliance","volume":"56","author":"Rijal","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.lansea.2023.100317_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0008429","article-title":"Long-term incidence of relapse and post-kala-azar dermal leishmaniasis after three different visceral leishmaniasis treatment regimens in Bihar, India","volume":"14","author":"Goyal","year":"2020","journal-title":"PLoS Negl Trop Dis"},{"issue":"5","key":"10.1016\/j.lansea.2023.100317_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1128\/mBio.00611-13","article-title":"Relapse after treatment with miltefosine for visceral leishmaniasis is associated with increased infectivity of the infecting Leishmania donovani strain","volume":"4","author":"Rai","year":"2013","journal-title":"mBio"},{"issue":"6","key":"10.1016\/j.lansea.2023.100317_bib8","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/S0035-9203(01)90110-5","article-title":"Ethiopian visceral leishmaniasis: generic and proprietary sodium stibogluconate are equivalent; HIV co-infected patients have a poor outcome","volume":"95","author":"Ritmeijer","year":"2001","journal-title":"Trans R Soc Trop Med Hyg"},{"issue":"8","key":"10.1016\/j.lansea.2023.100317_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0007653","article-title":"Relationship between treatment regimens for visceral leishmaniasis and development of post-kala-azar dermal leishmaniasis and visceral leishmaniasis relapse: a cohort study from Bangladesh","volume":"13","author":"Mondal","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"issue":"3","key":"10.1016\/j.lansea.2023.100317_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1002\/jrsm.1240","article-title":"Power analysis for random-effects meta-analysis","volume":"8","author":"Jackson","year":"2017","journal-title":"Res Synth Methods"},{"issue":"1","key":"10.1016\/j.lansea.2023.100317_bib12","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1002\/jrsm.1230","article-title":"Basics of meta-analysis: I2 is not an absolute measure of heterogeneity","volume":"8","author":"Borenstein","year":"2017","journal-title":"Res Synth Methods"},{"issue":"2","key":"10.1016\/j.lansea.2023.100317_bib13","doi-asserted-by":"crossref","first-page":"159","DOI":"10.4103\/0974-777X.62886","article-title":"Liposomal amphotericin B and leishmaniasis: dose and response","volume":"2","author":"Sundar","year":"2010","journal-title":"J\u00a0Glob Infect Dis"},{"key":"10.1016\/j.lansea.2023.100317_bib14","series-title":"A\u00a0language and environment for statistical computing","year":"2021"},{"issue":"3","key":"10.1016\/j.lansea.2023.100317_bib15","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.jclinepi.2009.05.008","article-title":"Empirical evaluation suggests Copas selection model preferable to trim-and-fill method for selection bias in meta-analysis","volume":"63","author":"Schwarzer","year":"2010","journal-title":"J\u00a0Clin Epidemiol"},{"issue":"n71","key":"10.1016\/j.lansea.2023.100317_bib16","first-page":"1","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"issue":"1","key":"10.1016\/j.lansea.2023.100317_bib17","first-page":"25","article-title":"Efficacy and safety of liposomal amphotericin B (AmBisome) for visceral leishmaniasis in endemic developing countries","volume":"76","author":"Berman","year":"1998","journal-title":"Bull World Health Organ"},{"issue":"6","key":"10.1016\/j.lansea.2023.100317_bib18","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1093\/clinids\/22.6.938","article-title":"Short-course treatment of visceral leishmaniasis with liposomal amphotericin B (AmBisome)","volume":"22","author":"Davidson","year":"1996","journal-title":"Clin Infect Dis"},{"issue":"7","key":"10.1016\/j.lansea.2023.100317_bib19","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0000764","article-title":"A curative immune profile one week after treatment of Indian kala-azar patients predicts success with a short-course liposomal amphotericin B therapy","volume":"4","author":"Mondal","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"1","key":"10.1016\/j.lansea.2023.100317_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pntd.0002613","article-title":"Safety and efficacy of single dose versus multiple doses of AmBisome\u00ae for treatment of visceral leishmaniasis in Eastern Africa: a randomised trial","volume":"8","author":"Khalil","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"issue":"10","key":"10.1016\/j.lansea.2023.100317_bib21","doi-asserted-by":"crossref","first-page":"e709","DOI":"10.1371\/journal.pntd.0000709","article-title":"Geographical variation in the response of visceral leishmaniasis to paromomycin in East Africa: a multicentre, open-label, randomized trial","volume":"4","author":"Hailu","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"issue":"6","key":"10.1016\/j.lansea.2023.100317_bib22","doi-asserted-by":"crossref","first-page":"e1674","DOI":"10.1371\/journal.pntd.0001674","article-title":"Sodium stibogluconate (ssg) & paromomycin combination compared to ssg for visceral leishmaniasis in east africa: a randomised controlled trial","volume":"6","author":"Musa","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lansea.2023.100317_bib23","doi-asserted-by":"crossref","first-page":"e1177","DOI":"10.1093\/cid\/ciac643","article-title":"Paromomycin and miltefosine combination as an alternative to treat patients with visceral leishmaniasis in Eastern Africa: a randomized, controlled, multicountry trial","volume":"76","author":"Musa","year":"2022","journal-title":"Clin Infect Dis"},{"key":"10.1016\/j.lansea.2023.100317_bib24","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1473-3099(10)70011-6","article-title":"Combination therapy for visceral leishmaniasis","volume":"10","author":"van Griensven","year":"2010","journal-title":"Lancet Infect Dis"},{"issue":"11","key":"10.1016\/j.lansea.2023.100317_bib25","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1046\/j.1365-3156.2001.00795.x","article-title":"A\u00a0policy for leishmaniasis with respect to the prevention and control of drug resistance","volume":"6","author":"Bryceson","year":"2001","journal-title":"Trop Med Int Health"},{"issue":"9","key":"10.1016\/j.lansea.2023.100317_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1371\/journal.pntd.0007726","article-title":"Field effectiveness of new visceral leishmaniasis regimens after 1 year following treatment within public health facilities in Bihar, India","volume":"13","author":"Goyal","year":"2019","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/j.lansea.2023.100317_bib27","first-page":"1","article-title":"The increasing incidence of visceral leishmaniasis relapse in South Sudan: a retrospective analysis of field patient data from 2001 \u2013 2018","author":"Naylor-leyland","year":"2022","journal-title":"PLoS Negl Trop Dis"},{"issue":"2","key":"10.1016\/j.lansea.2023.100317_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.pt.2013.12.004","article-title":"Post kala-azar dermal leishmaniasis: an unresolved mystery","volume":"30","author":"Mukhopadhyay","year":"2014","journal-title":"Trends Parasitol"},{"issue":"10","key":"10.1016\/j.lansea.2023.100317_bib29","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1086\/340219","article-title":"Relapses versus reinfections in patients coinfected with Leishmania infantum and human immunodeficiency virus type 1","volume":"185","author":"Morales","year":"2002","journal-title":"J\u00a0Infect Dis"}],"container-title":["The Lancet Regional Health - Southeast Asia"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368223001774?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772368223001774?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T09:52:24Z","timestamp":1757411544000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772368223001774"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,3]]},"references-count":28,"alternative-id":["S2772368223001774"],"URL":"https:\/\/doi.org\/10.1016\/j.lansea.2023.100317","relation":{},"ISSN":["2772-3682"],"issn-type":[{"value":"2772-3682","type":"print"}],"subject":[],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimating the proportion of relapse following treatment of Visceral Leishmaniasis: meta-analysis using Infectious Diseases Data Observatory (IDDO) systematic review","name":"articletitle","label":"Article Title"},{"value":"The Lancet Regional Health - Southeast Asia","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.lansea.2023.100317","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}],"article-number":"100317"}}